By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Acceleron Pharma 

128 Sidney Street

Cambridge  Massachusetts    U.S.A.
Phone: 617-649-9200 Fax: 617-649-9988




Alkermes plc 

Company News
Acceleron Pharma Initiates Phase 1 Clinical Trial With Innovative Muscle Drug ACE-083 10/14/2014 8:30:34 AM
Acceleron Pharma To Host Educational Webcast On Beta-Thalassemia 10/1/2014 10:11:11 AM
Acceleron Pharma To Host Educational Webcast On Beta-thalassemia 10/1/2014 9:47:27 AM
Acceleron Pharma To Webcast Presentation At Leerink Partners Rare Disease Roundtable 9/29/2014 11:48:22 AM
Acceleron Pharma Provides Update On Externally Sponsored Clinical Trial Of Dalantercept Monotherapy In Ovarian Cancer 9/23/2014 10:34:04 AM
Acceleron Pharma To Host Educational Webcast Series With Clinical Thought Leaders 9/16/2014 1:04:52 PM
Acceleron Pharma To Present At Upcoming Investor Conferences In September 8/27/2014 8:57:23 AM
Acceleron Pharma Reports Second Quarter 2014 Financial Results 8/12/2014 8:41:32 AM
How A Fluke Led Acceleron Pharma To A Crippling Blood Disease 7/18/2014 7:16:26 AM
Acceleron Pharma Appoints Terrence C. Kearney To Its Board Of Directors 7/14/2014 10:30:48 AM